News & Updates

Show Multimedia Only
Salbutamol may lower risk, improve prognosis of prostate cancer

Salbutamol may lower risk, improve prognosis of prostate cancer

14 Dec 2024

The incidence of prostate cancer is reduced among individuals treated with salbutamol, a short-acting beta-2 adrenergic agonist, according to a study.

14 Dec 2024
DISCREET highlights apremilast potential for genital psoriasis

DISCREET highlights apremilast potential for genital psoriasis

22 Oct 2024 byAudrey Abella

Individuals with psoriasis creeping into their intimate areas may find relief from apremilast, as shown by the week-32 improvements in multiple disease parameters in the phase III DISCREET study.

22 Oct 2024